Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of GLPG1972 Tablet Formulations
NCT04137341Phase 1Completed
- Sponsor
- Galapagos NV
- Start
- Oct 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of GLPG1972 in osteoarthritis (OA) (4 arms), sponsored by Galapagos NV. Primary endpoints: Area under the plasma concentration-time curve from time zero to last quantifiable concentration ratio, Area under the plasma concentration-time curve from time zero to infinity ratio and 4 more. Started Oct 2019; status: completed.
02
Drugs
GLPG1972
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04137341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04137341.